CRISPR Therapeutics AG (CRSP) Return on Capital Employed Growth (5y) (2021 - 2026)
CRISPR Therapeutics AG (CRSP) Return on Capital Employed Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - |
| 10 | CRISPR Therapeutics AG | 4.58 Bn | 4.58 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -555.00 |
| Dec 31, 2025 | -887.00 |
| Sep 30, 2025 | -851.00 |
| Jun 30, 2025 | -2,728.00 |
| Mar 31, 2025 | -2,495.00 |
| Dec 31, 2024 | -2,717.00 |
| Sep 30, 2024 | -1,326.00 |
| Jun 30, 2024 | 2,694.00 |
| Mar 31, 2024 | 2,530.00 |
| Dec 31, 2023 | 2,252.00 |
| Sep 30, 2023 | 706.00 |
| Jun 30, 2023 | 247.00 |
| Mar 31, 2023 | -380.00 |
| Dec 31, 2022 | -628.00 |
| Sep 30, 2022 | 185.00 |
| Jun 30, 2022 | 128.00 |
| Mar 31, 2022 | 3,655.00 |
| Dec 31, 2021 | 3,751.00 |